Related Experiment Video
Updated: Aug 19, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
Second mRNA Vaccination of COVID-19 in a Patient Who Developed Pericarditis after the First Vaccination
Yutaro Oshima1, Tsuyoshi Nozue1, Sohei Takagi1
1Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital.
Abstract:
The coronavirus infection 2019 (COVID-19) pandemic has led to the development of mRNA vaccines with proven efficacy. However, it remains unclear whether patients who developed pericarditis after the first COVID-19 mRNA would be fit to receive the second vaccination. Herein, we present the case of a 64-year-old man who visited our emergency department with substernal chest discomfort that began 4 days after his first mRNA COVID-19 vaccination. Acute pericarditis was diagnosed based on symptoms and ST-segment elevation on an electrocardiogram. Chest pain improved 2 days after treatment.Since there are no guidelines on whether to administer an additional vaccination to a patient who developed pericarditis after the initial vaccination, we considered whether or not to administer the additional vaccination. We informed the patient about the risks and benefits and decided to administer the second dose. He did not experience any major adverse reactions. The indications for the second vaccination need to be thoroughly considered.
Related Concept Videos
Myocarditis III: Medical Management
Pericarditis III: Medical Management
Pericarditis I: Introduction
Pericarditis IV: Nursing Management
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests

